Delivery Order SPE2DB22D1106-SPE2DB25FENZ8
Award Date
5/19/25
Potential Completion Date
5/20/25
Potential Value
$3.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CEFEPIME-DEXTROSE 2 GM/50 MLS, a pharmaceutical product, with a ceiling value of $14,307.57 and a period of performance through May 20, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CEFEPIME-DEXTROSE 2 GM/50 MLS, a pharmaceutical product, with a ceiling value of $3,813.38 and an ultimate completion date of May 19, 2025. The contract is a firm fixed-price, non-set-aside award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CEFEPIME-DEXTROSE 1 GM/50 MLS, a type of prescription medication. The contract has a firm fixed price, non-set-aside designation, and a ceiling value of $2,286.48. The ultimate completion date for this delivery order is May 20, 2025. Amerisourcebergen Drug Corp is the prime...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The contract is for the delivery of Cefepime-Dextrose 2 GM/50 ML medical supplies, with a ceiling value of $1,971.48 and a completion date of September 21, 2023. The contract is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,838.35, is for the supply of 4563433748 CEFEPIME-DEXTROSE 2 GM/50 MLS medical products. This is an open competition contract, with no set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CEFEPIME-DEXTROSE 2 GM/50 MLS, a pharmaceutical product, with a ceiling value of $17,370.01 and a performance period through May 19, 2025. The contract is a firm fixed-price delivery order, which is not set aside for any particular business type. Amerisourcebergen Drug Corp...
This is a Delivery Order contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) for the supply of the pharmaceutical product CEFEPIME-DEXTROSE 2 GM/50 MLS. The contract has a Firm Fixed Price pricing type and a ceiling value of $6,121.99. The ultimate completion date is May 10, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including to the...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of 4564404173 - CEFEPIME-DEXTROSE 2 GM/50 MLS, a pharmaceutical product. The contract is a firm fixed price delivery order with a ceiling value of $12,050.53 and a period of performance ending on April 26, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,023.24, is a delivery order for the supply of 4563866018 - CEFEPIME-DEXTROSE 2 GM/50 MLS, with a performance period ending on March 6, 2024. The contract is a firm fixed-price agreement and was not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant...
This federal contract award, valued at $1,038.52, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4566449785 CEFEPIME-DEXTROSE 2 GM/50 MLS, a medical product, with a completion date of November 18, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type, and it is not designated with a Set-Aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...